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Neurexins are essential presynaptic cell adhesion
molecules that are linked to schizophrenia and
autism and are subject to extensive alternative
splicing. Here, we used a genetic approach to test
the physiological significance of neurexin alternative
splicing. We generated knockin mice in which alter-
natively spliced sequence #4 (SS4) of neuexin-3 is
constitutively included but can be selectively excised
by cre-recombination. SS4 of neurexin-3 was chosen
because it is highly regulated and controls neurexin
binding to neuroligins, LRRTMs, and other ligands.
Unexpectedly, constitutive inclusion of SS4 in pre-
synaptic neurexin-3 decreased postsynaptic AMPA,
but not NMDA receptor levels, and enhanced post-
synaptic AMPA receptor endocytosis. Moreover,
constitutive inclusion of SS4 in presynaptic neu-
rexin-3 abrogated postsynaptic AMPA receptor
recruitment during NMDA receptor-dependent LTP.
These phenotypes were fully rescued by constitutive
excision of SS4 in neurexin-3. Thus, alternative
splicing of presynaptic neurexin-3 controls postsyn-
aptic AMPA receptor trafficking, revealing an
unanticipated alternative splicing mechanism for
trans-synaptic regulation of synaptic strength and
long-term plasticity.INTRODUCTION
Central synapses exhibit a large diversity in properties, such as
presynaptic release probability, postsynaptic receptor composi-
tion, and long-term plasticity. In a given neuron, these properties
depend on both the pre- and the postsynaptic neuron (Reyes
et al., 1998; Koester and Johnston, 2005). Trans-synaptic cell
adhesion molecules not only organize and synchronize assem-
bly of synapses, but also likely determine their properties anddiversity. Neurexins are trans-synaptic cell adhesion molecules
that are candidate molecules for mediating trans-synaptic spec-
ification of synaptic properties (Craig and Kang, 2007; Su¨dhof,
2008; Krueger et al., 2012).
Neurexins are expressed as a- and b-neurexins from indepen-
dent promoters in three genes (Ushkaryov et al., 1992, 1994;
Ushkaryov and Su¨dhof, 1993; Tabuchi and Su¨dhof, 2002; Rowen
et al., 2002). The larger a-neurexins are composed of six LNS
domains with three interspersed EGF-like domains followed by
a transmembrane region and a short cytoplasmic tail. The
smaller b-neurexins lack the N-terminal five LNS and three
EGF-like domains of a-neurexins but instead contain a unique
short N-terminal sequence. b-neurexins splice into the 6th LNS
domain of a-neurexins and are identical with a-neurexins in all
C-terminal sequences. The six principal neurexins (Nrx1a–3a
and Nrx1b–3b) are expressed in differential but overlapping pat-
terns in all neurons, such that most neurons synthesize multiple
a- and b-neurexins in different combinations (Ullrich et al., 1995).
In mice, triple knockout (KO) of Nrx1a, Nrx2a, and Nrx3a is
lethal despite continued expression of Nrx1b, Nrx2b, and
Nrx3b (Missler et al., 2003). a-neurexin triple KO mice die
because of a severe impairment in synaptic transmission.
Neurexins are assumed to be presynaptic because they act as
a-latrotoxin receptors (Ushkaryov et al., 1992; Sugita et al.,
1999) and because the a-neurexin triple KO phenotype sug-
gested a presynaptic function (Missler et al., 2003). However,
triple a-neurexin KO mice also displayed a postsynaptic pheno-
type (Kattenstroth et al., 2004), and recent studies in Drosophila
and C. elegans proposed a postsynaptic localization for neurex-
ins (Chen et al., 2012; Hu et al., 2012). The latter results are con-
sistent with at least some (Taniguchi et al., 2007) but not all
immunolocalization data (Ushkaryov et al., 1992), making it
uncertain whether neurexins act pre- or postsynaptically.
Mutations in the human Nrx1 (NRXN1) and Nrx2 (NRXN2) gene
have been associated with diverse neuropsychiatric disorders,
especially autism and schizophrenia (reviewed in Su¨dhof, 2008;
Reichelt et al., 2012). Changes in the human Nrx3 gene
(NRXN3) have also been associated with autism (Vaags et al.,
2012) and additionally linked to drug addiction and obesity (Hish-
imotoet al., 2007;Lachmanetal., 2007;Heard-Costaet al., 2009).Cell 154, 75–88, July 3, 2013 ª2013 Elsevier Inc. 75
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Neurexins are alternatively spliced at five canonical sites
(referred to as splice sites 1–5 [SS1–SS5]; Ullrich et al., 1995).
SS1, SS2, and SS3 are specific to a-neurexins, whereas SS4
and SS5 are present in both a- and b-neurexins. Neurexin alter-
native splicing is highly regulated. In particular, neurexin SS4
splice variants are differentially expressed in various brain re-
gions (Ullrich et al., 1995), exhibit a diurnal cycle (Shapiro-Reznik
et al., 2012), and are modulated by neuronal activity (Resnick
et al., 2008; Iijima et al., 2011; Rozic et al., 2012). These data sug-
gest that neurexin alternative splicing may be physiologically
important, but its biological significance has not been tested.
Neurexins bind to multiple postsynaptic cell adhesion mole-
cules, including neuroligins (Ichtchenko et al., 1995), dystrogly-
can (Sugita et al., 2001), LRRTMs (Ko et al., 2009; de Wit et al.,
2009; Siddiqui et al., 2010), GluRd2 via cerebellins (Uemura
et al., 2010), and CIRL/latrophilin (Boucard et al., 2012). Binding
of these ligands is modulated by neurexin alternative splicing at
SS4. SS4 exists in two forms that include (SS4+) or exclude
(SS4–) an alternatively spliced exon encoding 30 residues. Strik-
ingly, only SS4– neurexins bind to dystroglycan, CIRL/latrophilin,
and LRRTMs (Boucard et al., 2012; Ko et al., 2009; Siddiqui et al.,
2010; Sugita et al., 2001), whereas only SS4+ neurexins bind to
cerebellins (Matsuda and Yuzaki, 2011; Uemura et al., 2010).
Moreover, SS4– and SS4+ neurexins exhibit distinct affinities
for different isoforms of neuroligins, creating a ‘‘splice code’’ of
interactions (Boucard et al., 2005; Chih et al., 2006; Comoletti
et al., 2006). However, despite the known effect of SS4 alterna-
tive splicing on neurexin-ligand interactions and its mechanistic
understanding, it is unclear whether SS4 alternative splicing is
physiologically important. No approaches are available to
directly test the significance of alternative splicing for molecules
such as neurexins, which are alternatively processed at multiple
positions and whose overexpression in itself may produce bio-
logical effects. Apart from the fact that no KOs targeting both
a- and b-neurexins are available, such studies are made difficult
because rescue experiments cannot test all splice combinations
at physiological expression levels.
Here, we apply a genetic knockin approach to test the biolog-
ical significance of neurexin alternative splicing at SS4. Using
homologous recombination, we changed the splice-acceptor
sequence of the alternatively spliced SS4 exon, thereby convert-Figure 1. Genetic Switching of Alternative Splicing of Nrx3 at SS4 into
Transmission
(A) Absolute expression (number of transcripts/pg total RNA) of Nrx1a/b, Nrx2a/b
SS4+ and SS4– mRNAs in the same brain regions, as determined by quantitativ
(B) Knockin strategy to generate conditional Nrx3-SS4 mutant mice. The imperfe
SS4 exon 20 (E20) was replaced by homologous recombination in murine ES cells
flanked by LoxP sites. The resulting mutant Nrx3 gene constitutively expresse
constitutive expression of Nrx3-SS4– mRNA (Nrx3SS4–). Single letters indicate lo
(C) Quantification of Nrx3-SS4+, Nrx3-SS4–, and total Nrx3 mRNA levels in hipp
infected with lentiviruses expressing inactive cre-recombinase (retaining the Nrx
neurons). mRNA levels were normalized to those observed in WT neurons that e
(D and E) Representative traces (left) and summary graphs of the amplitude and
pocampal WT, Nrx3SS4+, and Nrx3SS4– neurons obtained as described for (C).
(F–H) Representative traces (left) and summary graphs (right) of evoked AMPAR
hippocampal WT, Nrx3SS4+, and Nrx3SS4– neurons.
Data in (C)–(H) are means ± SEM; numbers in bars give number of independe
analyzed (D–H). For (D)–(H), statistical significance was calculated by single-facting it into a constitutively includedexon that is no longer subject to
alternative splicing. At the same time, we rendered the SS4 exon
conditional by floxing it. Thus, we here describe a genetic
approach that allows conditional control of alternative splicing
of neurexinsandmaybegenerally applicable to vertebrategenes.
Using this approach, we found that constitutive expression of
Nrx3-SS4+ produced a selective alteration in postsynaptic
AMPA-receptor (AMPAR), but not NMDA-receptor (NMDAR) traf-
ficking, such that postsynaptic AMPAR levels were lowered, syn-
aptic strength was decreased, and NMDAR-dependent LTP was
attenuated. These phenotypes were fully reversed by cre-depen-
dent excision of the SS4 exon.Moreover, we found that the effect
of SS4 alternative splicing was not mediated by a cell-autono-
mous postsynaptic effect but, rather, by a trans-synaptic non-
cell-autonomous action of presynaptic Nrx3 on postsynaptic
neurons and that constitutive expression of Nrx3-SS4+ causes
a loss of the postsynaptic neurexin ligand LRRTM2. These results
provideadirect test of thephysiological functionof neurexin alter-
native splicing in vivo that was not possible with a nongenetic
approach and demonstrate an unanticipated mechanism by
which alternative splicing of a neurexin in a presynaptic neuron
trans-synaptically controls postsynaptic properties.
RESULTS
Region-Specific Alternative Splicing of Nrx3 at SS4
Although qualitative studies showed that alternative splicing of
neurexins at SS4 is highly regulated (Ullrich et al., 1995), no
quantitative assessment of neurexin alternative splicing is avail-
able. Thus, we developed quantitative reverse-transcriptase
PCR (qRT-PCR) assays for the alternatively spliced versions of
SS4 for Nrx1, Nrx2, and Nrx3 (Figure S1 available online) and
measured their messenger RNA (mRNA) levels in various brain
regions from adult mice (Figure 1A).
We found that the three neurexin genes were expressed at
comparable levels in different brain regions and exhibited a
coordinate but differential pattern of SS4 alternative splicing
(Figure 1A). Some brain regions (e.g., striatum and cerebellum)
expressed primarily (90%) SS4+ forms of all three neurexins.
Other brain regions (e.g., cortex and hippocampus) expressed
similar amounts of SS4+ and SS4– forms of Nrx1 and Nrx2 butConstitutive ‘‘On’’ or ‘‘Off’’ States Alters AMPAR-Mediated Synaptic
, and Nrx3a/bmRNAs in the indicated brain regions (top) and relative levels of
e RT-PCR (bottom; n = 4 mice; PVN, paraventricular nucleus).
ct splice acceptor sequence (SA; sequence in inset) of the alternatively spliced
with a perfect splice acceptor sequence (red letters); in addition, exon 20 was
s Nrx3-SS4+ mRNA (Nrx3SS4+). Cre-recombinase deletes the exon, causing
cations of restriction enzyme sites (C, ClaI; E, EcoRI; P, PstI).
ocampal neurons cultured from WT or Nrx3SS4+ mice; Nrx3SS4+ neurons were
3SS4+ genotype) or active cre-recombinase (converting Nrx3SS4+ into Nrx3SS4–
xpress predominantly Nrx3-SS4– mRNA (see A).
frequency (right) of mEPSCs (D) and mIPSCs (E), monitored in cultured hip-
- (F) and NMDAR-mediated EPSCs (G) and of evoked IPSCs (H) in cultured
nt culture experiments (C) or number of total cells/independent experiments
or ANOVA (**p < 0.01). See also Figure S1.
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primarily the SS4– form of Nrx3 (90%; Figure 1A). Thus, alter-
native splicing of neurexins at SS4 is regionally regulated, with
the largest differential in expression observed for Nrx3, prompt-
ing us to focus on this isoform.
Conditional Mutant Mice in Which SS4 Alternative
Splicing of Nrx3 Is Blocked
To test the role of SS4 alternative splicing of Nrx3, we sought
to develop a new genetic approach. We noted that the
alternatively spliced SS4 exon in the mouse Nrxn3 gene (exon
20; Tabuchi and Su¨dhof, 2002) contains an unusual purine-
rich splice acceptor sequence (Figure 1B). Using homologous
recombination in mouse embryonic stem cells, we converted
this imperfect splice acceptor sequence into a canonical
consensus sequence (Figure 1B). We also introduced flanking
loxP sites, such that exon 20 could be conditionally deleted.
Using this strategy, we obtained mutant mice that were
designed to constitutively insert the normally alternatively
spliced SS4 sequence into all Nrx3 mRNAs, thus rendering all
Nrx3 mRNAs SS4+ (referred to as Nrx3SS4+ genotype). At the
same time, these mutant mice allow exclusion of the SS4
sequence after cre-recombinase-mediated deletion of exon
20, rendering all Nrx3 mRNAs SS4– (referred to as Nrx3SS4–
genotype; Figure 1B).
Homozygous Nrx3SS4+ and Nrx3SS4– mice (obtained from
Nrx3SS4+ mice by germline deletion of exon 20) were viable
and fertile. To test the effectiveness of our genetic strategy, we
cultured hippocampal neurons from newborn wild-type (WT)
and Nrx3SS4+ mice. We infected WT neurons at DIV4–5 with
lentivirus-expressing GFP and the Nrx3SS4+ neurons with lentivi-
ruses expressing inactive or active cre-recombinase, thereby
producing controlled sets of cultured WT, Nrx3SS4+, and
Nrx3SS4– neurons. We then measured Nrx3-SS4+ and Nrx3-
SS4– mRNA levels in all three sets of neurons at DIV14–16. We
found that Nrx3SS4+ neurons expressed only Nrx3-SS4+ mRNAs
as predicted, whereas Nrx3SS4– neurons expressed only Nrx3-
SS4- mRNAs (Figure 1C). Total Nrx3 mRNA levels were not
significantly altered by either manipulation. Thus, we generated
mutant mice in which neurons produce only Nrx3-SS4+ mRNAs
but can be converted by cre-recombination to produce only
Nrx3-SS4- mRNAs.
Blocking SS4 Alternative Splicing of Nrx3 Alters
AMPAR-Mediated Responses
Electrophysiological recordings revealed that spontaneousmini-
ature excitatory postsynaptic currents (mEPSCs) exhibited a
significantly lower amplitude in Nrx3SS4+ than in WT or Nrx3SS4
neurons but displayed no change in frequency (Figures 1D, 1E,
and S1C). Neither the amplitude nor the frequency of sponta-
neous miniature inhibitory postsynaptic currents (mIPSCs) was
altered (Figures 1D, 1F, and S1E). The mEPSC or mIPSC rise
or decay kinetics and intrinsic properties of the neurons were
unchanged (Figures S1D and S1F). Neurexins are thought to
be presynaptic, whereas changes in the mEPSC amplitude
generally reflect postsynaptic changes. Thus, these findings
were surprising and suggested that alternative splicing of pre-
synaptic Nrx3 may alter excitatory synaptic strength by a post-
synaptic mechanism.78 Cell 154, 75–88, July 3, 2013 ª2013 Elsevier Inc.We next measured evoked excitatory postsynaptic currents
(EPSCs) mediated by AMPARs and NMDARs and inhibitory
postsynaptic currents (IPSCs) mediated by GABAA receptors.
We observed a large selective reduction (45%) in AMPAR-
mediated EPSCs in Nrx3SS4+ neurons compared to WT or
Nrx3SS4– neurons (Figure 1G). We detected no change in
NMDAR-mediated EPSCs or in IPSCs (Figures 1H and 1I).
Paired-pulse ratios (PPRs) of NMDAR EPSCs were identical in
WT, Nrx3SS4+, and Nrx3SS4– neurons (Figure S1F). Together,
these data suggest that SS4 alternative splicing selectively
alters postsynaptic AMPAR responses without changing
presynaptic neurotransmitter release or postsynaptic NMDAR
responses.
SS4 Alternative Splicing of All Neurexins Controls
Postsynaptic AMPARs
We next asked whether the decrease in AMPAR-mediated
EPSCs in Nrx3SS4+ neurons can be reversed by expression of
different neurexins in an SS4-dependent manner. We superin-
fected WT, Nrx3SS4+, and Nrx3SS4– neurons at DIV4–5 with
lentiviruses expressing either control GFP or ‘‘rescue’’ neurexins
and measured evoked AMPAR-mediated EPSCs at DIV14–16
(Figure 2).
We found that both Nrx3a-SS4– and Nrx3b-SS4– cDNAs
rescued the decrease in AMPAR responses in Nrx3SS4+ neurons
without affecting AMPAR responses in WT or Nrx3SS4– neurons
(Figures 2A and 2B). In contrast, the Nrx3b-SS4+ cDNA did
not rescue the decreased AMPAR responses in Nrx3SS4+
neurons. Moreover, we observed that Nrx1b-SS4– and
Nrx2b-SS4– fully rescued the decreased AMPAR phenotype
in Nrx3SS4+ neurons, whereas Nrx1b-SS4+ and Nrx2b-SS4+
did not (Figures 2C and 2D). Thus, alternative splicing of all
neurexins at SS4 redundantly controls postsynaptic AMPAR
responses.
Nrx3SS4+ Decreases Postsynaptic AMPAR Levels and
Increases AMPAR Endocytosis
We labeled surface AMPARs in cultured WT, Nrx3SS4+, and
Nrx3SS4– neurons with antibodies to the extracellular sequences
of the AMPAR subunits GluA1 and GluA2. We fixed and permea-
bilized the GluA1-stained neurons and stained them for the
intracellular presynaptic marker vGluT1 and the postsynaptic
marker PSD95 (Figure S2A). Quantification of surface GluA1-
and GluA2-containing puncta or of intracellular vGluT1- or
PSD95-containing puncta did not reveal a difference in synapse
density between WT, Nrx3SS4+, and Nrx3SS4– neurons (Figures
3A, 3B, and S2B; for absolute values, see Figure S2C). However,
the size of postsynaptic GluA1- and GluA2-containing surface
clusters was 40%–50% smaller in Nrx3SS4+ neurons than in
WT and Nrx3SS4– neurons, whereas the size of PSD95- or
vGluT1-containing clusters was not significantly altered (Fig-
ure 3B). The decrease in GluA1 and GluA2 puncta size was uni-
formly distributed among synapses (Figure 3C). No effect on
AMPAR intensity (i.e., the amount of AMPARs per area) was
observed (Figure S2B).
To determine why the Nrx3SS4+ genotype decreased postsyn-
aptic AMPAR levels, we measured GluA1 internalization in
cultured hippocampal neurons (Lin et al., 2000). We incubated
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Figure 2. Reduced AMPAR-Mediated Syn-
aptic Responses in Nrx3SS4+ Synapses Are
Rescued by SS4–, but Not SS4+, Neurexins
(A–D) Representative traces (left) and summary
graphs (right) of evoked AMPAR-mediated peak
EPSC amplitudes measured in hippocampal
neurons that were cultured from WT or Nrx3SS4+
mice; Nrx3SS4+ neurons were infected with lenti-
viruses expressing inactive cre-recombinase
(which leaves the genotype unchanged) or active
cre-recombinase (which converts the Nrx3SS4+
into the Nrx3SS4- genotype). Neurons were super-
infected with a second lentivirus expressing either
no neurexin (control) or the indicated Nrx1-3 iso-
forms and splice variants.
Data are means ± SEM; numbers in bars repre-
sent total number of cells/experiments analyzed.
Statistical significance was calculated by single-
factor ANOVA (*p < 0.05; **p < 0.01; and ***p <
0.001).WT, Nrx3SS4+, and Nrx3SS4– neurons briefly (5 min) with an
antibody to the extracellular N terminus of GluA1, followed by
a 15 min chase (Figure S2D). We then fixed the neurons without
permeabilization, labeled them with an AlexaFluor488-tagged
secondary antibody (green) to mark surface GluA1 receptors,
permeabilized the neurons, and labeled them with a different
secondary antibody that was AlexaFluor546 tagged (red) to
detect internalized GluA1 receptors (Figure 3D).
Strikingly, we found that GluA1 internalization was increased
60% in Nrx3SS4+ neurons compared to WT and to Nrx3SS4–Cell 154,neurons, which exhibited identical values
(Figure 3E). Taken together, these data
show that the constitutive inclusion of
SS4 in Nrx3 decreases postsynaptic sur-
face AMPARs and accelerates AMPAR
endocytosis.
Presynaptic Membrane-Tethered
Nrx3 Controls Postsynaptic
AMPARs
To test whether Nrx3-SS4– acts pre- or
postsynaptically to stabilize postsynaptic
AMPARs, we sparsely transfected neu-
rons. We then measured whether post-
synaptically expressed Nrx3-SS4– could
rescue the decrease in AMPAR re-
sponses in Nrx3SS4+ neurons (Figure 4A).
We observed no difference between
Nrx3SS4+ neurons without or with post-
synaptic ‘‘rescue’’ by Nrx3-SS4–, sug-
gesting that postsynaptic Nrx3 cannot
stabilize postsynaptic AMPAR levels.
To confirm this conclusion, we
asked whether cre-recombinase-medi-
ated postsynaptic conversion ofNrx3SS4+
into Nrx3SS4– rescues AMPAR levels in a
neuron (Figure 4B). Again, we failed toobserve rescue, suggesting that postsynaptic Nrx3 does
not contribute to the regulation of postsynaptic AMPARs
and arguing by default that Nrx3 must act by a presynaptic
mechanism.
Does presynaptic Nrx3b-SS4– stabilize AMPARs via an intra-
or extracellular interaction? We addressed this question by
testing a fusion protein composed of the extracellular Nrx3b
sequences and the PDGF receptor transmembrane region
(Figure 4C). Strikingly, this protein fully rescued the decreased
AMPAR EPSCs in Nrx3SS4+ neurons but only when SS4 was75–88, July 3, 2013 ª2013 Elsevier Inc. 79
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Figure 3. Constitutive Inclusion of SS4 in Nrx3 in Hippocampal Nrx3SS4+ Neurons Decreases AMPAR Surface Levels and Increases AMPAR
Internalization
(A) Representative images of hippocampal neurons cultured from WT or Nrx3SS4+ mice; Nrx3SS4+ neurons were infected with lentiviruses expressing either
inactive (retaining the Nrx3SS4+ genotype) or active cre-recombinase (switching the Nrx3SS4+ to the Nrx3SS4– genotype). Neurons were surface labeled for GluA1
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(D and E) Representative images (D) and summary graph (E) of GluA1 endocytosis analyzed in WT,Nrx3SS4+, andNrx3SS4- neurons obtained as described above.
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Data are the means ± SEM of four independent experiments. Statistical analyses were performed by single-factor ANOVA (*p < 0.05; **p < 0.01; and ***p < 0.001).excised. This result shows that no intracellular Nrx3 sequences
are required for stabilizing AMPARs but raises the interesting
question of whether naturally occurring secreted splice variants80 Cell 154, 75–88, July 3, 2013 ª2013 Elsevier Inc.of Nrx3 encoded by some inserts in SS5 that contain a stop
codon might also rescue the Nrx3SS4+ phenotype. In other
words, could Nrx3-SS4– act as a paracrine factor?
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Figure 4. Presynaptic Membrane-Tethered,
but Not Secreted, Nrx3b-SS4– Controls
Postsynaptic AMPARs in a Non-Cell-Auton-
omous Fashion
(A) Representative traces (left) and summary
graphs (right) of evoked AMPAR EPSCsmonitored
in hippocampal neurons cultured from WT or
Nrx3SS4+ mice. Nrx3SS4+ neurons were sparsely
transfected at DIV4–5 with plasmids encoding
EGFP alone or EGFP and Nrx3b-SS4– and were
analyzed by whole-cell patch-clamp recordings at
DIV14–16.
(B) Same as (A) except that neurons were sparsely
transfected with plasmids encoding inactive
(control) or active cre-recombinase (Cre-Rec.).
(C) Representative traces (left) and summary
graphs of AMPAR-mediated EPSC amplitudes
in hippocampal neurons that were cultured
from WT or Nrx3SS4+ mice and infected with len-
tiviruses expressing inactive cre-recombinase
(which retains the Nrx3SS4+ genotype) or active
cre-recombinase (which converts Nrx3SS4+ into
Nrx3SS4– neurons). Neurons were superinfected
with lentivirus expressing control or rescue
cDNAs encoding fusion proteins of the extracel-
lular Nrx3b-SS4+ and -SS4– sequences with the
PDGF-receptor transmembrane region.
(D) Same as (C) except that the rescue cDNAs
express a naturally occurring splice variant of
Nrx3b that encodes secreted Nrx3b-SS4+ and
Nrx3b-SS4–.
Data are means ± SEM; numbers in bars represent
total cells/experiments performed. Statistical sig-
nificance was calculated by single-factor ANOVA
(**p < 0.01 and ***p < 0.001).However, we found that secreted Nrx3b—independent of the
SS4 splice variant—was unable to rescue AMPAR EPSCs in
Nrx3SS4+ neurons, suggesting that membrane tethering of the
Nrx3 extracellular sequences is essential (Figure 4D).
Nrx3-SS4 Alternative Splicing Controls AMPAR
Responses in Vivo
Although cultured neurons allow a quantitative definition of syn-
aptic parameters such as synaptic strength, cultured neurons
lack some properties of neural networks, such as a defined
cytoarchitecture or long-term plasticity. Moreover, differentia-
tion between pre- and postsynaptic effects can be difficult in
cultured neurons. To address these issues, we analyzed the
effects of Nrx3-SS4 alternative splicing in presynaptic CA1 neu-
rons of the hippocampus at synapses formed onto postsynaptic
pyramidal neurons in the subiculum (Figure 5A). The subiculum is
the major synaptic output for hippocampal CA1 neurons but
additionally receives synapses from the entorhinal, perirhinal,
and prefrontal cortex (O’Mara, 2005). We decided to analyzeCell 154,the CA1 subiculum synapse because it
is amenable to specifically presynaptic
manipulations by stereotactic injection
of viruses into the CA1 region (Xu et al.,
2012). This approach allowed us to
record from uninfected subicular neu-rons receiving inputs from infected CA1 neurons and thus
enabled us to selectively probe the effect of presynaptic alterna-
tive splicing of Nrx3 on postsynaptic AMPAR responses
(Figure 5A).
We stereotactically injected the hippocampal CA1 region of
WT or Nrx3SS4+ mice at P21 with control or cre-recombinase ex-
pressing adeno-associated viruses (AAVs) and analyzed the
mice at P35–42. EGFP expression documented that the CA1 re-
gion and dentate gyrus of the hippocampus, but not the subicu-
lum or the CA3 region, were infected (Figure 5A). Thus, the
infected CA1 pyramidal neurons exhibit a WT genotype, an
Nrx3SS4+ genotype (control virus in Nrx3SS4+ mice, referred to
as CA1Ctrl), or an Nrx3SS4- genotype (cre-expressing virus in
Nrx3SS4+ mice, referred to as CA1Cre). We sectioned horizontal
slices (300 mm) from the dorsal hippocampus of injected mice,
stimulated CA1 axons with an extracellular electrode placed in
the alveus/stratum oriens at the border of the CA1 pyramidal
layer and the subiculum, and recorded from subicular pyramidal
neurons (Figure 5A).75–88, July 3, 2013 ª2013 Elsevier Inc. 81
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Figure 5. Cre-Mediated In Vivo Conversion of Presynaptic Nrx3SS4+ to Nrx3SS4– in the Hippocampal CA1 Region Restores Impaired AMPAR-
Mediated Synaptic Responses in Nrx3SS4+ Postsynaptic Neurons in the Subiculum
(A) Representative images illustrating the selective expression of EGFP in the CA1 region of the dorsal hippocampus after stereotactic injection of AAVs and the
recording configuration used for measuring synaptic transmission from the CA1 region to the subiculum. Mice were stereotactically injected at P21 and analyzed
at P35. Note the complete infection of CA1 region neurons without spillover into the subiculum (S).
(B) AMPAR-to-NMDAR ratios recorded in acute slices in pyramidal neurons of the dorsal subiculum after in vivo presynaptic manipulations of Nrx3-SS4 alter-
native splicing in the hippocampal CA1 region (top, representative EPSC traces at 65 mV [AMPAR] and +40 mV [NMDAR]; bottom, average ratios). WT mice
were stereotactically injected into the hippocampal CA1 region with AAVs encoding GFP (black traces/bars) and Nrx3SS4+ mutant mice with AAVs encoding
inactive (Nrx3SS4+-CA1Ctrl; blue traces/bars) or active cre-recombinase (Nrx3SS4+-CA1Cre; green traces/bars).
(C) Input/output relationship of postsynaptic AMPAR EPSCs in regular firing neurons of the subiculum as a function of presynaptic Nrx3-SS4 alternative splicing.
Data show sample traces (left), summary curves (middle), and average input/output slopes (right) for slices obtained as described in (B).
(D) Paired-pulse measurements of postsynaptic AMPAR EPSCs in regular firing neurons of the subiculum as a function of presynaptic Nrx3-SS4 alternative
splicing. Data show sample traces (left) and summary graphs (right) for samples obtained as described in (B).
(E and F) Same as (C) and (D) but recorded from burst-firing neurons in the subiculum.
Data shown aremeans ±SEM; number of neurons/mice analyzed are shown in the bars. Statistical analyses for summary graphs were performed by single-factor
ANOVA (*p < 0.05 and **p < 0.01). For additional data, see Figure S3.
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We first measured the AMPAR-to-NMDAR ratio. Strikingly, the
AMPAR/NMDAR ratio was significantly decreased in Nrx3SS4+-
CA1Ctrl, but not in Nrx3SS4+-CA1Cre neurons, compared to WT
controls (Figure 5B). This result is consistent with a selective
decrease in AMPAR, but not NMDAR, responses observed in
culturedNrx3SS4+ neurons, suggesting that Nrx3-SS4 alternative
splicing bidirectionally and trans-synaptically regulates postsyn-
aptic AMPAR responses in vivo (Figures 1G and 1H).
To confirm that presynaptic Nrx3-SS4 alternative splicing reg-
ulates postsynaptic AMPARs, we measured AMPAR-mediated
input-output curves. The subiculum contains two types of pyra-
midal neurons, regular and burst firing neurons. These neurons
differ in firing patterns (Figure S3A) and express different forms
of LTP but receive similar inputs and exhibit comparable basal
transmission properties (Taube, 1993; Staff et al., 2000; Menen-
dez de la Prida et al., 2003; Wozny et al., 2008). Both regular and
burst-firing subicular neurons displayed a significant decrease in
AMPAR-mediated synaptic responses in Nrx3SS4+-CA1Ctrl neu-
rons compared to either WT or Nrx3SS4+-CA1Cre neurons, con-
firming a decrease in AMPAR-mediated responses (Figures 5C
and 5E). We also measured paired-pulse ratios in regular and
burst-firing subicular neurons to identify possible presynaptic
changes but detected none (Figures 5D, 5F, S3B, and S3C).
Viewed together, these data indicate that, in adult mice in vivo,
constitutive inclusion of SS4 in presynaptic Nrx3mRNAs causes
a selective and highly significant decrease in postsynaptic
AMPAR responses that can be reversed by removal of the
SS4 exon.
Constitutive Presynaptic Nrx3-SS4+ Expression Impairs
Postsynaptic LTP
In regular firing neurons of the subiculum, the threshold for LTP
induction is high, and LTP is mediated by a postsynaptic,
NMDAR-dependent mechanism similar to classical LTP at
Schaffer-collateral CA1-region synapses of the hippocampus
(Wozny et al., 2008). By contrast, in burst-firing neurons, the
LTP induction threshold is low and LTP is mediated by a presyn-
aptic mechanism that increases the probability of glutamate
release. Although the mechanisms of LTP differ between the
two types of neurons, LTP induction appears to require Ca2+
influx via NMDA receptors in both (Figure S4;Wozny et al., 2008).
We induced LTP in acute slices from WT, Nrx3SS4+-CA1Ctrl,
and Nrx3 SS4+-CA1Cre mice by four 100 Hz tetani separated by
10 s and measured LTP induction in regular and burst-firing neu-
rons. We observed a marked reduction (70%) of LTP in regular
firing neurons from Nrx3SS4+-CA1Ctrl mice compared to WT and
Nrx3SS4+-CA1Cre mice (Figures 6A and 6B). We detected no
decrease in paired-pulse ratio after LTP induction in regular firing
neurons in any genotype, in agreement with the finding that LTP
in these neurons is postsynaptic (Figures 6B, S4B, and S4C).
In contrast to regular firing neurons, we observed no signifi-
cant difference in LTP in burst-firing neurons in slices from
Nrx3SS4+-CA1Ctrl, Nrx3SS4+-CA1Cre, and WT mice (Figures 6C
and 6D). Consistent with the previously described presynaptic
mechanism of LTP in burst-firing neurons (Wozny et al., 2008),
we found that LTP induction in burst-firing neurons caused a sig-
nificant decrease in the paired-pulse ratio in all three genotypes
(Figure 6D). Taken together, these data demonstrate that consti-tutive presynaptic expression of Nrx3-SS4+ impairs postsyn-
aptic LTP in regular firing neurons.
Constitutive Nrx3-SS4+ Expression Decreases
Postsynaptic LRRTM2 Levels
The reduction of AMPAR-mediated basal synaptic transmission
and the block of LTP by presynaptic Nrx3-SS4+ suggests that
presynaptic Nrx3-SS4– may interact with one or several post-
synaptic ligand(s) that control postsynaptic AMPAR levels. Two
neurexin ligands are linked to AMPARs, neuroligins (Chubykin
et al., 2007; Etherton et al., 2011), and LRRTMs (de Wit et al.,
2009; Schwenk et al., 2012). Moreover, reduction of neuroligin
and LRRTM levels in postsynaptic neurons specifically impaired
AMPAR-mediated transmission in vivo (Soler-Llavina et al.,
2011). Furthermore, we recently found that LRRTM knockdown
in vivo severely impairs NMDAR-mediated LTP (Soler-Llavina
et al., 2013). Thus, we tested whether the postsynaptic levels
of LRRTM2 (the major LRRTM isoform in the hippocampus)
and neuroligin-1 (the major neuroligin isoform of excitatory syn-
apses) were altered by Nrx3-SS4+ expression (Figures 7A–7C
and S5). Strikingly, we found that the apparent postsynaptic sur-
face levels of LRRTM2 were decreased 45%, whereas neuro-
ligin-1 did not exhibit a significant change. These data support
the notion that presynaptic Nrx3-SS4– acts to enable postsyn-
aptic AMPAR retention by activating LRRTM2 and possibly other
ligands.
DISCUSSION
Alternative splicing of neurexins is highly regulated and controls
neurexin binding to multiple ligands, but its biological signifi-
cance is unknown. Using a genetic strategy, we here addressed
this question. We focused on alternative splicing of Nrx3 at SS4,
which is particularly strongly regulated (Figure 1A) and controls
Nrx3 binding to neuroligins, LRRTMs, cerebellins, dystroglycan,
and CIRL/latrophilin (Ichtchenko et al., 1995; Sugita et al., 2001;
Ko et al., 2009; Siddiqui et al., 2010; Uemura et al., 2010;
Boucard et al., 2012). Alternative splicing of Nrx3 at SS4
involves inclusion or exclusion of a single exon that exhibits an
unusual purine-rich splice acceptor sequence (Tabuchi and
Su¨dhof, 2002). We converted this noncanonical splice-acceptor
sequence into a canonical splice-acceptor sequence to render
the exon constitutively ‘‘spliced in’’ and flanked the SS4 exon
with loxP sites to allow the exon to be constitutively ‘‘spliced
out’’ by cre-recombinase (Figures 1B and Figure 1C). Different
from traditional approaches, such as conditional knockout-
and-rescue methods, this genetic approach does not alter
expression of the endogenous gene and does not interfere with
other alternative splicing events. The genetic approach that we
developed here enabled us to examine the role of neurexin alter-
native splicing in vivo andmay be generally applicable for studies
of the physiological significance of alternative splicing.
Using the genetic tool that we generated, we demonstrate that
alternative splicing of presynaptic Nrx3 at SS4 trans-synaptically
regulates the strength of excitatory synapses by controlling
postsynaptic AMPAR levels. Thus, we describe a mechanism
of trans-synaptic control of postsynaptic receptors by a presyn-
aptic ligand. Although neurexin alternative splicing has beenCell 154, 75–88, July 3, 2013 ª2013 Elsevier Inc. 83
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Figure 6. Nrx3SS4+ Mice Exhibit Impaired Postsynaptic NMDAR-Dependent LTP that Is Rescued by Conversion of Presynaptic Nrx3SS4+
Neurons into Nrx3SS4– Neurons
(A) LTP in regular firing neurons. Acute slices were analyzed by whole-cell recordings in the subiculum from WT mice and from Nrx3SS4+ mice in which CA1
neurons were transduced in vivo by stereotactic injection of AAV encoding inactive (Ctrl) or active cre-recombinase (Cre). Data show representative traces (top)
and summary graphs of the relative synaptic strength (bottom) monitored before and after induction of LTP. LTPwas induced by 43 100 Hz stimuli applied for 1 s
with 10 s intervals in current-clamp configuration at resting membrane potential. Following the LTP induction, cells were held at 65 mV in voltage clamp to
measure evoked EPSCs. Representative traces shown are EPSCs during baseline (1) and 50 min after induction (2).
(B) EPSC amplitudes averaged over the last 10 min of the LTP recordings and normalized to the baseline (left) and paired-pulse ratios with a 40 ms interstimulus
interval measured 10min pre-LTP induction and 60min post-LTP induction (right) from regular firing neurons in the subiculum following presynaptic manipulation
of Nrx3-SS4.
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Figure 7. Nrx3SS4+ Neurons Contain
Decreased Postsynaptic Concentrations of
LRRTM2: Model for the Mechanism of
Action of Nrx3-SS4 Alternative Splicing
(A) Representative images of hippocampal neu-
rons stained for surface-localized LRRTM2 or
neuroligin-1 (NL1). Neurons were cultured from
WT or Nrx3SS4+ mice; the latter were infected
with lentiviruses expressing either inactive cre-
recombinase (which retains the Nrx3SS4+ geno-
type) or active cre-recombinase (which switches
Nrx3SS4+ into Nrx3SS4- neurons).
(B) Quantification of the density (left) and size
(right) of LRRTM2 or neuroligin-1-positive puncta
in WT, Nrx3SS4+, and Nrx3SS4– neurons. Data are
means ± SEM; n = 3 independent culture experi-
ments; statistical analyses were performed by
Student’s t test (*p < 0.05).
(C) Cumulative probability distribution of the
puncta size in WT, Nrx3SS4+, and Nrx3SS4– neu-
rons. Statistical significance was assessed by the
Kolmogorov-Smirnov test (***p < 0.001). See also
Figure S5.
(D) Model of how presynaptic Nrx3 may stabilize
postsynaptic AMPARs in an SS4-dependent
manner via trans-synaptic interactions with neu-
roligins and/or LRRTMs. Postsynaptic AMPAR
stability is dependent on the presynaptic expres-
sion of Nrx3-SS4– that lacks an insert at splice site
4 and preferentially interacts with neuroligins and
LRRTMs. Neuroligins and LRRTMs have been
shown to interact with AMPARs (Etherton et al.,
2011; Soler-Llavina et al., 2011; Schwenk et al.,
2012), possibly via their binding to PSD95, which in
turn binds to the C-terminal sequences of TARPs
that form a tight complex with AMPARs (Schnell
et al., 2012). The data in (A)–(C) suggest that
the Nrx3-LRRTM interaction is most important for
controlling postsynaptic AMPAR levels, but dif-
ferent isoforms of neuroligin differentially interact
with the two Nrx3-SS4 splice variants, and thus a
major contribution of interactions of neurexins with
neuroligins or other ligands in controlling post-
synaptic AMPARs cannot be ruled out.extensively studied in vitro (Ullrich et al., 1995; Resnick et al.,
2008; Iijima et al., 2011), its significance was unknown. Our
data thus show that alternative splicing of neurexins is indeed
physiologically important and, at least for SS4, has amajor effect
on synaptic transmission. In Nrx3-SS4+ neurons, the number of
synapses was unchanged, as evidenced by the lack of change
in synapse density, mEPSC frequency, and NMDAR-mediated
EPSCs. However, the synaptic levels of AMPARs were
decreased, as evidenced by decreased GluA1 and GluA2
puncta sizes, decreasedmEPSC amplitudes, decreased evoked
AMPAR-mediated EPSCs, and increased AMPAR endocytosis
(Figures 1 and 3). Viewed together, these data suggest that pre-
synaptic Nrx3-SS4–, but not Nrx3-SS4+, produces anchoring
sites for postsynaptic AMPARs (Figure 7D).
In controlling postsynaptic AMPAR levels, neurexins act
strictly presynaptically, as shown by the specifically pre- and
postsynaptic manipulations that we performed in vitro (Figure 4)
and in vivo (Figures 5 and 6). Thus, our results reveal a pathway
of trans-synaptic signaling and offer a potential explanation forthe observation that the properties of a synapse are determined
by a trans-synaptic interaction between pre- and postsynaptic
elements (Reyes et al., 1998; Koester and Johnston, 2005).
Our data also suggest a mechanism by which alternative
splicing of presynaptic neurexins may control postsynaptic
AMPAR content. Presynaptic membrane-tethered Nrx3 was suf-
ficient for stabilizing postsynaptic AMPARs, whereas secreted
Nrx3 was inactive (Figure 4). Thus, presynaptic neurexins likely
connect to a postsynaptic ligand. Neurexins interact with several
postsynaptic ligands in a largely competitive manner, most
importantly with neuroligins and LRRTMs (Figure 7D). These in-
teractions form a dynamic interaction network in which the post-
synaptic neurexin ligands in turn interact with other ligands (e.g.,
see Lee et al., 2013). The relative concentrations and alternative
splicing of neurexins and their ligands determine the state of the
network. This dynamic interaction network results in a binding
equilibrium whereby not a single neurexin binding reaction can
explain all of the observed actions of neurexins, but the overall
state of the network determines the properties of a synapse.Cell 154, 75–88, July 3, 2013 ª2013 Elsevier Inc. 85
Among neurexin ligands, both neuroligins and LRRTMs regu-
late AMPARs (Chubykin et al., 2007; de Wit et al., 2009; Etherton
et al., 2011; Soler-Llavina et al., 2011; Schnell et al., 2012).
Strikingly, we found that postsynaptic LRRTM2 is decreased in
Nrx3-SS4+ neurons (Figures 7A–7C). LRRTM2 binds only to
SS4– neurexins (Ko et al., 2009; Siddiqui et al., 2010), suggesting
that neurexins control AMPARs by binding to LRRTMs, although
neuroligins may also contribute because they differentially
interact with both SS4+ and SS4– neurexins (Ichtchenko et al.,
1995; Boucard et al., 2005; Chih et al., 2006). Given the impor-
tance of SS4 in regulating ligand interactions of neurexins, it
seems likely that SS4 is a central regulator of the neurexin-based
dynamic protein-interaction network. Changing alternative
splicing of Nrx3 at SS4 may shift this network without altering
other neurexin functions, thereby producing the AMPAR pheno-
type that we observed (Figure 7D).
Finally, our study unexpectedly identifies a presynaptic molec-
ular event that is required as a permissive signal for normal
postsynaptic NMDAR-dependent LTP, indicating that the pre-
synaptic terminal can ‘‘gate’’ postsynaptic LTP. Specifically,
we show that alternative splicing of SS4 in Nrx3 not only
regulates constitutive AMPAR trafficking, but also enables
activity-dependent recruitment of AMPARs during LTP induction
(Figure 6). The decades-old debate of whether NMDAR-depen-
dent LTP is pre- or postsynaptically induced was resolved
when LTP was found to be induced by recruitment of AMPARs
to synapses (Kerchner and Nicoll, 2008). Although LTP is
clearly postsynaptically induced, our results show that LTP
induction nevertheless requires presynaptic ‘‘permission,’’
thereby rendering LTP under control of both pre- and postsyn-
aptic neurons (Figure 6). This permission is likely mediated by
Nrx3 binding to LRRTMs, as LRRTM knockdowns also produce
a decrease in LTP (Soler-Llavina et al., 2013). Thus, a presynap-
tic mechanism surprisingly controls postsynaptically induced
long-term synaptic plasticity.
We would like to emphasize that the selective phenotype
that we observed in Nrx3-SS4+ neurons does not mean that
regulating AMPAR levels is the only function of Nrx3 or even
of Nrx3-SS4 alternative splicing. It seems likely that Nrx1,
Nrx2, and Nrx3 have overlapping functions based on our rescue
experiments (Figure 2) and previous studies (Missler et al., 2003).
Presumably, the phenotype produced bymanipulating only Nrx3
reflects neurexin functions that are incompletely compensated
for by the other two neurexins, possibly because the other neu-
rexins are not coexpressed at sufficiently high levels in the
affected synapses. It seems likely that the AMPAR phenotype
will be even more severe in mice carrying SS4 mutations in mul-
tiple neurexins. Moreover, alternative splicing of neurexins at
SS4 may also mediate trans-synaptic control of other synaptic
receptors.
How do the present results then relate to previous genetic
studies on a-neurexin triple KO mice, which reported changes
in the presynaptic release machinery and in postsynaptic
NMDARs instead of AMPARs (Kattenstroth et al., 2004; Missler
et al., 2003)? It should be noted that there is neither overlap in
phenotypes nor overlap in genetic manipulations between the
previous and current studies. In the previous studies, all a-neu-
rexins were deleted but b-neurexins were normally expressed,86 Cell 154, 75–88, July 3, 2013 ª2013 Elsevier Inc.whereas in the present study, alternative splicing of both Nrx3a
and Nrx3b at SS4 was selectively altered with continued unal-
tered expression of all a- and b-neurexins. The fact that these
disparatemanipulations have distinct effects supports the notion
that neurexins perform multiple independent functions via
different domains that are regulated by distinct events of alterna-
tive splicing. Such functional diversity is consistent with the
many ligands observed for neurexins, which form a complex dy-
namic interaction network, and emphasizes the critical role that
neurexins play in synaptic transmission.
EXPERIMENTAL PROCEDURES
In all experiments, the experimenter was blinded to the sample genotype. All
plasmids are available upon request, and the mice described here were
deposited in Jackson Labs for distribution.
Mouse Generation and Husbandry
Nrx3SS4+ mutant mice were generated by homologous recombination (Fig-
ure 1B), and Nrx3SS4– mice were produced by cre-recombinase mediated
deletion of exon 20 in the germline of Nrx3SS4+ mutant mice (Kaeser et al.,
2011). All mouse work was approved by animal use committees at Stanford
University (for details, see the Extended Experimental Procedures).
mRNA Measurements
mRNAmeasurements were performed using quantitative RT-PCR with b-actin
as the endogenous internal control. For primer sequences and assay valida-
tions, see the Extended Experimental Procedures.
Virus Preparations
All lentiviruses were constructed as described using the synapsin promoter to
drive expression (Kaeser et al., 2011). AAVs were constructed as described
using a CMV-actin-globin promoter. For details, see the Extended Experi-
mental Procedures.
Hippocampal Neurons
Hippocampal neurons were cultured from newborn WT and Nrx3SS4+ mice
(Kaeser et al., 2011), infected on DIV4–5 with lentiviruses, and analyzed at
DIV13–16. Rescue experiments were performed by concurrent superinfection
of neurons with rescue viruses. Transfections used the calcium phosphate
method.
AMPAR Imaging Experiments
AMPAR imaging experiments were performed and quantified as described
(Aoto et al., 2008; Lin et al., 2000). For details, see the Extended Experimental
Procedures.
Stereotactic Injections
Stereotactic injections of AAVs were performed as described (Xu et al., 2012).
Efficiency and localization of AAV expression were confirmed by histochemis-
try of nuclear GFP encoded by the expressed inactive and active GFP-cre-
recombinase fusion proteins.
Electrophysiology
Recordings from cultured neurons and acute slice electrophysiology were per-
formed essentially as described (Kaeser et al., 2011; Etherton et al., 2011;
Wozny et al., 2008). For details, see the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
five figures and can be found with this article online at http://dx.doi.org/10.
1016/j.cell.2013.05.060.
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